230 related articles for article (PubMed ID: 19171671)
21. Ethanol inhibition of lateral orbitofrontal cortex neuron excitability is mediated via dopamine D1/D5 receptor-induced release of astrocytic glycine.
Nimitvilai-Roberts S; Gioia D; Zamudio PA; Woodward JJ
Neuropharmacology; 2021 Jul; 192():108600. PubMed ID: 33965399
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress reduces renal dopamine D1 receptor-Gq/11alpha G protein-phospholipase C signaling involving G protein-coupled receptor kinase 2.
Banday AA; Lokhandwala MF
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F306-15. PubMed ID: 17459951
[TBL] [Abstract][Full Text] [Related]
23. Dopamine activity in the lateral anterior hypothalamus modulates AAS-induced aggression through D2 but not D5 receptors.
Schwartzer JJ; Melloni RH
Behav Neurosci; 2010 Oct; 124(5):645-55. PubMed ID: 20939664
[TBL] [Abstract][Full Text] [Related]
24. Dopamine induces a biphasic modulation of hypothalamic ANF neurons: a ligand concentration-dependent effect involving D5 and D2 receptor interaction.
Lee D; Huang W; Lim AT
Mol Psychiatry; 2000 Jan; 5(1):39-48. PubMed ID: 10673767
[TBL] [Abstract][Full Text] [Related]
25. Local application of dopamine inhibits pyramidal tract neuron activity in the rodent motor cortex.
Awenowicz PW; Porter LL
J Neurophysiol; 2002 Dec; 88(6):3439-51. PubMed ID: 12466459
[TBL] [Abstract][Full Text] [Related]
26. Sexual behavior modulates contextual fear memory through dopamine D1/D5 receptors.
Bai HY; Cao J; Liu N; Xu L; Luo JH
Hippocampus; 2009 Mar; 19(3):289-98. PubMed ID: 18853437
[TBL] [Abstract][Full Text] [Related]
27. A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism.
Hasbi A; Perreault ML; Shen MY; Zhang L; To R; Fan T; Nguyen T; Ji X; O'Dowd BF; George SR
FASEB J; 2014 Nov; 28(11):4806-20. PubMed ID: 25063849
[TBL] [Abstract][Full Text] [Related]
28. Dopamine receptor oligomerization visualized in living cells.
O'Dowd BF; Ji X; Alijaniaram M; Rajaram RD; Kong MM; Rashid A; Nguyen T; George SR
J Biol Chem; 2005 Nov; 280(44):37225-35. PubMed ID: 16115864
[TBL] [Abstract][Full Text] [Related]
29. Modulation by GTP of basal and agonist-stimulated striatal adenylate cyclase activity following chronic blockade of D1 and D2 dopamine receptors: involvement of G proteins in the development of receptor supersensitivity.
Schettini G; Ventra C; Florio T; Grimaldi M; Meucci O; Marino A
J Neurochem; 1992 Nov; 59(5):1667-74. PubMed ID: 1402912
[TBL] [Abstract][Full Text] [Related]
30. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
Keefe KA; Gerfen CR
Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
[TBL] [Abstract][Full Text] [Related]
31. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
32. Coupling of D1 and D5 dopamine receptors to multiple G proteins: Implications for understanding the diversity in receptor-G protein coupling.
Sidhu A
Mol Neurobiol; 1998 Apr; 16(2):125-34. PubMed ID: 9588624
[TBL] [Abstract][Full Text] [Related]
33. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J
J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061
[TBL] [Abstract][Full Text] [Related]
34. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms.
Tseng KY; O'Donnell P
J Neurosci; 2004 Jun; 24(22):5131-9. PubMed ID: 15175382
[TBL] [Abstract][Full Text] [Related]
35. D1- and D2-receptor mediation of motoric behavior in rats depleted of DA as neonates: effects of age and size of depletion.
Byrnes EM; Johnson BJ; Bruno JP
Neurosci Lett; 1994 Nov; 181(1-2):69-72. PubMed ID: 7898774
[TBL] [Abstract][Full Text] [Related]
36. Activation of spinal d1/d5 receptors induces late-phase LTP of C-fiber-evoked field potentials in rat spinal dorsal horn.
Yang HW; Zhou LJ; Hu NW; Xin WJ; Liu XG
J Neurophysiol; 2005 Aug; 94(2):961-7. PubMed ID: 15829590
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of hormonally induced inositol trisphosphate production in Transfected GH4C1 cells: A novel role for the D5 subtype of the dopamine receptor.
White BH; Kimura K; Sidhu A
Neuroendocrinology; 1999 Mar; 69(3):209-16. PubMed ID: 10087453
[TBL] [Abstract][Full Text] [Related]
38. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
Huang Y; Qiu AW; Peng YP; Liu Y; Huang HW; Qiu YH
Neuro Endocrinol Lett; 2010; 31(6):782-91. PubMed ID: 21196914
[TBL] [Abstract][Full Text] [Related]
39. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy.
D'Aoust JP; Tiberi M
Cell Signal; 2010 Jan; 22(1):106-16. PubMed ID: 19786093
[TBL] [Abstract][Full Text] [Related]
40. Modulation of Ca2+ signals by phosphatidylinositol-linked novel D1 dopamine receptor in hippocampal neurons.
Ming Y; Zhang H; Long L; Wang F; Chen J; Zhen X
J Neurochem; 2006 Aug; 98(4):1316-23. PubMed ID: 16771826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
